We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

98 hedge funds and large institutions have $641M invested in Aerie Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 12

56% more capital invested

Capital invested by funds: $410M → $641M (+$231M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more funds holding

Funds holding: 76 → 98 (+22)

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

Holders
98
Holders Change
+22
Holders Change %
+28.95%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
34
Increased
28
Reduced
25
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$54.2M
2
JHIU
Janus Henderson Investors US
Colorado
+$17M
3
NHAS
Novo Holdings A/S
Denmark
+$10.6M
4
BFA
BlackRock Fund Advisors
California
+$8.23M
5
Stifel Financial
Stifel Financial
Missouri
+$7.52M

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$33M
2
DM
Deerfield Management
New York
-$11.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.4M
4
Goldman Sachs
Goldman Sachs
New York
-$5.63M
5
PA
Perceptive Advisors
New York
-$5.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4M +$21.5K +846 +0.6%
Millennium Management
27
Millennium Management
New York
$3.98M +$1.45M +57,024 +72%
HCM
28
Harvey Capital Management
Florida
$3.95M -$25.4K -1,000 -0.7%
DCM
29
DAFNA Capital Management
California
$3.87M -$327K -12,900 -9%
EI
30
EAM Investors
California
$3.79M +$947K +37,327 +40%
State Street
31
State Street
Massachusetts
$3.77M +$225K +8,890 +7%
Asset Management One
32
Asset Management One
Japan
$3.53M +$2.98M +117,427 New
FAM
33
Fred Alger Management
New York
$3.26M +$2.83M +111,548 New
DCM
34
Driehaus Capital Management
Illinois
$3.11M +$2.7M +106,559 New
MSA
35
Mason Street Advisors
Wisconsin
$3.04M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.67M +$299K +11,808 +15%
CWG
37
C WorldWide Group
Denmark
$2.65M -$991K -39,097 -30%
SFM
38
Sphera Funds Management
Israel
$2.58M -$1.9M -75,000 -46%
CCI
39
Columbus Circle Investors
$2.51M -$880K -34,685 -29%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$2.39M +$146K +5,738 +8%
WA
41
Wasatch Advisors
Utah
$2.24M -$394K -15,539 -17%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$2.23M +$346K +13,652 +22%
USAA
43
United Services Automobile Association
Texas
$2.14M +$91.8K +3,620 +5%
RFC
44
Russell Frank Company
Washington
$2.08M +$108K +4,250 +6%
PIM
45
Platinum Investment Management
Australia
$1.72M – – –
KCM
46
Kennedy Capital Management
Missouri
$1.55M +$915K +36,066 +211%
BCA
47
Benchmark Capital Advisors
New York
$1.43M +$48.2K +1,900 +4%
TCIM
48
TIAA CREF Investment Management
New York
$1.22M -$68.7K -2,708 -6%
Ameriprise
49
Ameriprise
Minnesota
$1.2M +$55.1K +2,172 +6%
BAMCO Inc
50
BAMCO Inc
New York
$1.16M +$629K +24,800 +165%
1
2
3 4 5

AERI Hedge Fund Activity: Q4 2014 in Review

98 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2014, worth a combined $641M — up 56% from $410M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AERI positions and 12 closed out — a net gain of 22 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was Jennison Associates, adding an estimated $54.2M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $33M.

  • 98 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2014, up from 76 in Q3 2014.
  • Funds reported $641M of Aerie Pharmaceuticals stock for Q4 2014, up 56% quarter-over-quarter.
  • 34 funds opened new Aerie Pharmaceuticals positions in Q4 2014 and 12 closed out, a net change of +22 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2014 was Jennison Associates, an estimated $54.2M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2014 was TPG Group Holdings (SBS) Advisors, an estimated $33M sold.

Based on aggregated 13F filings for Q4 2014.